TARRYTOWN, N.Y., Oct. 7, 2016 /PRNewswire/ -- Regeneron
Pharmaceuticals, Inc. (NASDAQ:REGN) today announced that it
will report its third quarter 2016 financial and operating results
on Friday, November 4, 2016, before
the U.S. financial markets open. The Company will host a
conference call and simultaneous webcast at 8:30 AM Eastern Time that day.
Conference Call Information
To access this call, dial
(888) 771-4371 (U.S.) or (847) 585-4405 (International). A
link to the webcast may be accessed from the 'Events and
Presentations' page of Regeneron's website at
www.regeneron.com. A replay of the conference call and
webcast will be archived on the Company's website and will be
available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron
(NASDAQ: REGN) is a leading science-based biopharmaceutical company
based in Tarrytown, New York that
discovers, invents, develops, manufactures, and commercializes
medicines for the treatment of serious medical conditions.
Regeneron commercializes medicines for eye diseases, high LDL
cholesterol and a rare inflammatory condition, and has product
candidates in development in other areas of high unmet medical
need, including rheumatoid arthritis, asthma, atopic dermatitis,
pain, oncology, and infectious diseases. For additional information
about the company, please visit www.regeneron.com or follow
@Regeneron on Twitter.
Contact
Information:
|
|
|
|
Investor
Relations
|
Corporate
Communications
|
Manisha Narasimhan,
Ph.D.
|
Hala Mirza
|
914.847.5126
|
914.847.3422
|
manisha.narasimhan@regeneron.com
|
hala.mirza@regeneron.com
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/regeneron-to-report-third-quarter-2016-financial-and-operating-results-and-host-conference-call-and-webcast-on-november-4-2016-300340914.html
SOURCE Regeneron Pharmaceuticals, Inc.